跳至主要内容
临床试验/NCT01242046
NCT01242046撤回不适用

The Effects of Caffeine on Female Genital Arousal

University of Texas at Austin2 个研究点 分布在 1 个国家开始时间: 2010年11月16日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Sexual arousal

研究概览

简要总结

The key research question in this study is whether or not caffeine facilitates genital sexual arousal in women in the presence of an external erotic stimulus. Caffeine's impact on the human sexual response cycle has yet to be studied in the field, so the goal is to determine if this substance will have any impact on genital arousal well as potentially identify the mechanisms underlying its ability to do so. Considering that this will be a single blind study, a key goal of the project is to determine how participant expectations regarding what they ingest will impact their subjective sexual arousal. At present, we hypothesize that, as caffeine's stimulant properties increase a human's heart rate and blood pressure, caffeine intake will facilitate genital arousal.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 18 or older
  • Heterosexual
  • Experiencing regular menstrual cycles (not more than 1 missed menstrual period in the past 6 months).
  • Currently involved in a stable, sexually active relationship.
  • Fluent in the English language.

排除标准

  • Self-report of sexual aversion or distress; or of distress related to a history of unwanted or coercive sexual contact.
  • Perimenopausal or menopausal status, or >1 missed menstrual period in the previous 6 months; or currently pregnant, breastfeeding, or having breastfed within the past 3 months; or clinically significant untreated renal or endocrine disease.
  • History of HIV infection or active, untreated pelvic, vaginal, or urinary tract infection including sexually transmitted diseases such as chlamydia, genital herpes, gonorrhea, or syphilis.
  • Previous major pelvic surgery that may have caused nerve damage, including hysterectomy, vulvectomy, circumcision, colostomy, cystostomy, or serious bladder, rectal, or abdominal surgery; or neurological impairment due to diabetes, stroke, pelvic nerve damage secondary to trauma, cancer treatments, myasthenia gravis, multiple sclerosis or spinal cord damage.
  • Self-report of an untreated psychosis (e.g., bipolar disorder or schizophrenia).
  • Women who do not use caffeine products regularly (i.e., on a daily basis).
  • Women receiving any of the following medications will be excluded from the study, as they have been shown to alter sexual function or arousal response: Dehydroepiandrosterone (DHEA), testosterone and other androgens, estrogens (except oral contraceptives), progesterone, tamoxifen, raloxifene, and other selective estrogen receptor modulators (SERMs), Beta blockers or other drugs that affect the autonomic nervous system and/or cardiovascular system, any approved or experimental medications or treatments used to enhance the sexual response (e.g., sildenafil), and antidepressants

结局指标

主要结局

Sexual arousal

时间窗: 15 minutes post administration of drug or placebo

Vaginal pulse amplitude, as measured by a vaginal photoplethysmograph

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tierney Kyle Ahrold Lorenz

Researcher

University of Texas at Austin

研究点 (2)

Loading locations...

相似试验